[{"Assets_0_Q2_USD":218541000.0,"CommonStockSharesOutstanding_0_Q2_shares":73877000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-73449000.0,"NetIncomeLoss_1_Q2_USD":-42194000.0,"NetIncomeLoss_2_Q2_USD":-80296000.0,"StockholdersEquity_0_Q2_USD":49307000.0,"Ticker":"VSTM","CIK":"1526119","name":"VERASTEM, INC.","OfficialName":"Verastem Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"309307156.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190801"}]